Table 2.
Whole-genome amplification (WGA) methods used for CTC analysis.
| Method | Application | Advantage (s) | 
|---|---|---|
| Pure PCR-based amplification | Amplifying specific sites in the genome | Better uniformity of amplification | 
| MDA-based methods | Point mutations amplification to analyze the genome of patient-derived CTCs | Higher fidelity than PCR-based methods | 
| MALBAC combining MDA and PCR-based methods | Analysis of single-nucleotide variants (SNVs) | Intermediate coverage and uniformity | 
| LIANTI | Amplifies T7-promoter-tagged DNA fragments into thousands of RNA copies | Covers 97% of the genome with a reduced false-negative rate | 
| GenomPlex and Ampli1 | Copy-number variation (CNV) profiling | Significantly higher genomic coverage | 
Pure PCR-based amplification (DOP-PCR), multiple displacement amplification [70], degenerate oligonucleotide-primed polymerase chain reaction, multiple annealing- and looping-based amplification cycles (MALBAC), or linear amplification via transposon insertion (LIANTI).